(Q57877411)

2

object named as

O Kirk

0 references

Amanda Mocroft

1

object named as

A Mocroft

0 references

author name string

P Aldins

3

0 references

A Chies

4

0 references

A Blaxhult

5

0 references

N Chentsova

6

0 references

N Vetter

7

0 references

J Gatell

9

0 references

JD Lundgren

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

10

0 references

publication date

May 2008

0 references

published in

HIV Medicine

0 references

volume

9

0 references

issue

5

0 references

page(s)

261-269

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

A national HIV community cohort: design, baseline, and follow-up of the AmFAR Observational Database. American Foundation for AIDS Research Community-Based Clinical Trials Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

Interval and Clinical Cohort Studies: Epidemiological Issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

Antiretroviral therapy in a thousand patients with AIDS in Haiti

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

Participation in research and access to experimental treatments by HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

Participation in clinical studies among patients infected with HIV-1 in a single treatment centre over 12 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00557.X